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The gradual decline of cognitive ability with age, even in the absence of overt brain disease,
is a growing problem. Although cognitive aging is a common and feared accompaniment
of the aging process, its underlying mechanisms are not well understood and there are
no highly effective means to prevent it. Additional research on cognitive aging is sorely
needed, and methods that enable ready translation between human subjects and animal
models stand to provide the most benefit. Here and in the six companion pieces in this
special issue, we discuss a variety of challenges and opportunities for studying cognitive
aging across species. We identify tests of associative memory, recognition memory,
spatial and contextual memory, and working memory and executive function as cognitive
domains that are age-sensitive and amenable to testing with parallel means in both
humans and animal models. We summarize some of the important challenges in using
animal models to test cognition.We describe unique opportunities to study cognitive aging
in human subjects, such as those provided by recent large-scale initiatives to characterize
cognition in large groups of subjects across the lifespan. Finally, we highlight some of the
challenges of studying cognitive aging in human subjects.
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INTRODUCTION
One of the great successes of the last century was a dramatic
increase in life expectancy, which increased in the United States
from 49.2 years in 1902 to around 78 years today (Congressional
Research Service, 2006). With the many benefits of increased
longevity, however, come the burdens of aging, among the most
feared of which is the potential decline of cognitive ability. The
effects of aging on cognition have traditionally been divided into
three trajectories. The most severe decline is associated with age-
related diseases, such as Alzheimer’s disease and other neurode-
generative dementias. At the other end of the spectrum are those
who maintain high levels of cognitive function as the age, often
termed successful aging (Rowe and Kahn, 1987). But the most
common trajectory is somewhere between these two extremes:
those who escape from succumbing to age-related disease but still
experience a gradual impairment of cognition that is sometimes
called “normal aging” and will be referred to here as cognitive
aging. Cognitive aging begins as early as the fifth decade (Singh-
Manoux et al., 2012) and can negatively impact quality of life.
The rapidly growing population of older Americans makes it crit-
ical that we develop new strategies to treat and prevent cognitive
aging.
Cognitive aging can be studied in both human subjects and
animal models, and each approach presents unique advantages
and disadvantages. Without doubt, the gold standard for cogni-
tive aging studies is research with human populations. Human
subject research is necessary to describe the epidemiology of this
problem, define which cognitive domains are most susceptible to
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decline with aging, understand the cognitive processes mediat-
ing these declines, and to test potential interventions. But human
studies have important constraints, particularly the limited abil-
ity to test hypotheses regarding neural substrates of age-related
cognitive decline through experimental manipulations. Animal
models are much better suited for these experiments, since
they allow for neuropathological examination at different time
points and for experimental manipulations that aren’t possible
in human subjects. The issue, of course, is identifying animal
models and outcome measures that are most relevant to human
cognitive aging and have the best predictive value for identifying
therapeutic strategies. Thus, there is a need for complemen-
tary approaches that allow facile translation of findings across
species.
To address these issues, the McKnight Brain Research
Foundation (tmbrf.org) convened a working group of scientists
from the four McKnight Brain Institutes, which are devoted to
studying cognitive aging. This group was charged with evaluating
the current challenges and opportunities for studying cognitive
aging across species. In the six companion pieces in this special
issue, we make recommendations on suitable assays for charac-
terizing cognitive aging in human populations and both rodent
and non-human primate models. Here, we summarize our find-
ings and review overarching issues regarding studies of cognitive
aging across species.
OPPORTUNITIES WITH ANIMAL MODELS
In reviewing the literature on animal models of cognitive aging,
we set three criteria by which to select models and tests for con-
sideration. First, the test must probe a cognitive domain that is
known to decline with aging in both humans and in the ani-
mal model. Second, there must be some understanding of the
anatomic substrate of the test, either a circumscribed region or
a distributed network, with the rationale that a cognitive test in
animal models is more likely to have relevance to human sub-
jects if it is mediated by a conserved anatomical region/network.
For this reason, despite the fact that some lower organisms have
age-dependent declines on learning and memory tasks, our dis-
cussion is limited for the most part to mammalian models,
primarily rodents and non-human primates, which have brain
networks homologous to humans. Third, the ideal outcome mea-
sures should be those that can be evaluated in both human
subjects and animal models using tests that bear as much sim-
ilarity as possible, again to maximize cross-species predictive
validity.
Applying these criteria, we identified four cognitive domains
that pose excellent opportunities for studying cognitive aging
in animal models. First, associative memory can be assessed by
classical eyeblink conditioning, is age-dependent, and relies on
both cerebellar and hippocampal circuits across species (Engle
and Barnes, 2012). Second, recognition memory can be assessed
by object recognition tasks, is age-dependent, and relies on the
perirhinal cortex across species (Burke et al., 2012, which includes
further discussion of cases in which the hippocampus proper may
also be involved, e.g., Reed and Squire, 1997; Zola and Squire,
2001). Third, spatial and contextual memory can be assessed with
multiple tasks, is age-dependent, and relies on the hippocampal
formation across species (Foster et al., 2012). And fourth, work-
ing memory and executive function can be assessed with a variety
of cross-species tasks, are age-dependent, and rely on prefrontal
cortex across species (Bizon et al., 2012). Details on the his-
tory of these cognitive domains, the evidence for their conserved
anatomy and age-dependence across species, and strategies for
testing them in animal models are presented in the companion
articles in this issue.
CHALLENGESWITH ANIMAL MODELS
While the availability of tests for associative, recognition, spa-
tial/contextual, and working memory in animal models poses
tremendous opportunities, there are a variety of challenges to
these studies. In particular, there are many external variables that
affect performance on these tests and must be carefully controlled
to generate reliable and reproducible data.
EFFECTS OF DIURNAL VARIATION AND TIMING
The light cycle timing of vivarium facilities is a major factor
in several lines of animal research, including neuroscience and
endocrinology. By default, many investigators who study noctur-
nal rodents use a standard light dark cycle (LD) in synchrony
with work schedules (12 h light starting at 6 am and 12 h dark
starting at 6 pm, termed a 12:12 LD cycle). Another popular
alternative is a 14:10 LD cycle. Because rodents are in the inac-
tive phase of their circadian rhythm during the daylight hours,
some behavioral assays are better administered during the dark
phase of the cycle (Hossain et al., 2004). Inverted light cycles,
i.e., 12:12 DL, allow performing nocturnal experiments during
normal working hours. However, careful attention must be paid
to maintaining darkness during dark cycle experiments, as even
minimal amounts of light during the dark cycle can disrupt the
circadian rhythms with downstream effects on many neurophys-
iological parameters (Reiter, 1991). This variable is not an issue,
of course, with non-human primates, who have circadian patterns
much like those in humans.
EFFECTS OF PRE-HANDLING AND TEST ORDER
On some tests, naïve rodents behave differently than rodents that
have been handled or have previously undergone other behav-
ioral assays (Holmes and Rodgers, 1998; Võikar et al., 2004).
Thus, protocols for pre-handling before testing and standardiza-
tion of test order become important. Generally, rodents should
be handled daily for several days prior to experimentation. The
goal of animal pre-handling is to acclimatize the animals to
being picked up, restrained, and placed in position. Further,
daily handling is particularly important in the context of aging
with regard to minimizing stress and to provide opportunities to
identify pathophysiological changes (e.g., tumor growth, urinal
plugs, etc.). When multiple investigators are involved in ani-
mal studies, consistent handling parameters should be observed
and all investigators should handle the animals regularly before
experimentation. Adaptation of non-human primates to research
personnel, primate holding chairs in which behavioral tests
are administered, and the experimental routine of the study is
also crucial for reducing variability among animals in any age
group.
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EFFECTS OF SINGLE VS. GROUP HOUSING
Rodents are social animals and the degree of social interac-
tions can have a profound effect on cognitive parameters. For
example, animals socially isolated after weaning can perform
better in the water maze (Wongwitdecha and Marsden, 1996).
Therefore, the degree and timing of social isolation (single hous-
ing) should be clearly indicated. This holds true for non-human
primates as well. One of us (Carol A. Barnes) has successfully pair-
housed opposite-sex pairs for behavioral and electrophysiological
experiments, and some labs pair-house same-sex, mature female
monkeys or even groups of up to eight young males (Barnes and
Baxter, personal communication).
EFFECTS OF SOURCE/VENDOR AND HOUSING CONDITIONS
Rodent contextual fear conditioning results can vary between
mice of the same strain purchased from different vendors
(Curzon et al., 2009). In aging research, most groups rely on the
NIA rodent aging colony, thus minimizing vendor differences.
However, some groups maintain their own colonies, particularly
for the study of transgenic lines. The details of colony mainte-
nance can affect animal behavior, as each vivarium facility has
unique characteristics that can contribute to inter-institutional
variability. Difficult to control issues such as noise levels and
building vibrations can contribute to chronic stress and affect
both the aging process and learning and memory. Further, the
effect of the local climate (e.g., heat and humidity in Florida) can
influence animals during transport and housing in older facilities.
Controllable factors include frequency of cage changes, animal
and cage density, chow, light cycle, and the use of ventilated cages.
A number of National Primate Research Centers (e.g.,
California, Oregon, Yerkes, etc.) breed and maintain rhesus
macaques and have detailed records of health and exposure to
traumatic incidents across their lifespan.
EFFECTS OF BACKGROUND STRAIN
Rodent experiments can be performed on different inbred and
outbred background strains, which can vary considerably in their
abilities on cognitive tasks (Crawley et al., 1997). This emphasizes
the importance of a consistent genetic background, and if one is
studying age-related decline in ability, a background strain that
is capable of performing the task at young ages. For non-human
primates, while a direct experimental comparison of cognition
has not been conducted on Indian- versus Chinese-derived rhesus
macaques, there appear to be notable differences in temperament
between these genetic backgrounds, which can, of course, affect
cognitive outcomes.
As discussed below and in the companion article by
Geldmacher et al. (2012) an important consideration in screening
human subjects for cognitive studies is the identification of any
sensory abnormalities (e.g., hearing or visual impairment) that
might impair task performance independent of cognitive ability.
Similar issues arise in animal model studies of cognitive aging, as
some background strains develop age-dependent sensory abnor-
malities. For example, C57BL/6 mice display age-related hearing
loss (Johnson et al., 1997) that can affect tests based on auditory
cues. For non-human primates, useful tests of visual and auditory
function across aging animals can be conducted using standard
visual-evoked potential tests, tests of auditory brain responses, as
well as more standard exams.
EFFECTS OF SPECIFIC PROTOCOL PARAMETERS
In addition to these general considerations, most tasks have spe-
cific aspects of the protocol that can affect results significantly,
such as the number and spacing of trials. Key parameters for each
task are discussed in the companion articles.
CHALLENGES WITH INTERPRETATION OF BEHAVIOR DATA
In some cases, it can be challenging to relate certain findings in
animal models to human disease. For example, increased time
spent exploring the open arms of the elevated plus maze could
reflect decreased anxiety, increased risk taking, disinhibition, or
hyperactivity. Obviously, these interpretive challenges are greater
with tasks that have less relation to those used with human sub-
jects. To mitigate this issue, we have tried to focus on tasks with
as much “face validity”, or similarity in task performance between
human subjects and animal models, as possible.
OPPORTUNITIES WITH HUMAN SUBJECTS
While experimental approaches have provided a wealth of infor-
mation on age-related cognitive changes, the field would clearly
benefit from the expansion of standardized research approaches
to cognitive assessment in human aging studies. Several col-
laborative efforts have been developed to pursue these over
the last decade, and each has strengths and weaknesses when
viewed from the perspectives of (1) characterizing longitudinal
changes within aging populations, (2) characterizing individual
differences within aging populations, (3) aligning with the phe-
nomenology and design of experiments to study cognitive aging
in non-human species, and (4) adaptability for use by physicians
and other health care providers who must differentiate the effects
of healthy cognitive aging from incipient neurologic disease.
One these collaborations is the “NIH Toolbox for Assessment
of Neurological and Behavioral Function” (www.nihtoolbox.org)
which was established by the NIH to develop a common set of
instruments to measure cognitive, emotional, motor and sensory
function across diverse cultural, ethnic and geographic groups
(Gershon et al., 2010). Participants range from age 3 to 85. From
the cognitive aging perspective, a major shortcoming of the initial
studies developing the toolbox is the allocation of adults from age
18 to 69 in a single age group, with another group ranging in age
from 70 to 85. Individuals over 85, a rapidly increasing propor-
tion of the population, are not included. In contrast, participants
between the ages of 3–17 are studied in single year age cohorts.
Given the substantial differences in cognition between people at
age 18 and 69, extensive research will be needed to understand
the utility of the toolbox’s tests for longitudinal studies in aged
samples.
A second large NIH-funded project involves assessment of
executive cognitive function. Systematic definition of executive
function has proved elusive. For instance, one review found
that anywhere from one to four factors emerged as significant
contributors to executive function (Royall et al., 2002), and
these are variably sensitive to the aging process. In 2006, the
NINDS funded the project “Domain Specific Tasks of Executive
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Function,” commonly known as EXAMINER, to develop a neu-
ropsychological test battery which could reliably and validly assess
domains of executive function (examiner.ucsf.edu). Preliminary
evidence from 212 healthy adults over age 55 shows a significant
negative correlation between a composite executive function score
and age (Kramer, 2010). However, although executive function
changes may be important contributors to cognitive aging, the
EXAMINER project has not focused on other domains, especially
those that most closely overlap with experimental paradigms
useful in non-human species.
Substantial cognitive performance data has been collected by
the NIA’s Alzheimer’s Disease Centers program since its incep-
tion in 1984. Since 2005, the Centers have collected a uniform
data set of typical neuropsychological performance measures.
This battery now also serves as the core cognitive assessment
for another NIH collaborative effort, the Alzheimer’s Disease
Neuroimaging Initiative. The testing was intended to take no
more than 30min to administer, and includes assessments of
(1) attention, (2) processing speed, (3) executive function, (4)
episodic memory, and (5) language. Data on over 3600 cog-
nitively normal subjects has been reported (Weintraub et al.,
2009). Design of the battery was driven by pragmatic and
disease-oriented considerations rather than by changes expected
in healthy cognitive aging. Data is made freely available to
investigators who request it (www.alz.washington.edu/WEB/
researcher-home.html). However, there was no overt attempt to
link the assessments to testing available in non-human species.
From the perspective of the medical provider, none of these
battery approaches offers an ideal solution to office-based assess-
ment of cognition. They are time-consuming and require special
training or equipment. Additionally, copyright issues for some
assessments, including the commonly used Mini-Mental State
Examination, might become prohibitive in light of low reim-
bursement for these services by healthcare insurers. However, as
the population of oldest adults grows dramatically over the com-
ing decades, there will be increasing need for well-validated tools
for assessment of cognition in aging and detection of diseases
causing cognitive impairment. Public health agencies have recog-
nized this need as well, and beginning in 2011, the US Centers for
Medicare and Medicaid Services have made provision for reim-
bursement for assessment of cognitive function as part of an
annual wellness visit.
The time therefore seems ripe for a coordinated and systematic
approach to developing a library of tests useful to the researcher
specifically interested in human cognitive aging, which can be
directly linked to studies in non-human species and tap simi-
lar processes across multiple species. As noted above, domains of
(1) associative memory, (2) recognition memory, (3) spatial and
contextual memory, (4) working memory and executive func-
tion, and (5) visual perception offer the most promise. There
is a rich body of human literature in each of these domains,
and the influence of aging on performance is well supported.
Specific experimental techniques for understanding the effects of
aging in these and other domains will be reviewed by Alexander
et al. (2012). We anticipate that a clearer understanding of the
basis of cognitive aging in humans and non-human species will
emerge from this approach. Additionally, gaps in knowledge that
result from differences in experimental approaches can be iden-
tified, and used as a blueprint for development of new research
assessments in either humans or non-human species. Improved
understanding of the common physiologic basis and phenotypic
expression of cognitive aging across species can also serve as the
focal point for rationally designed and clinically practical tests,
which would improve the ability of practicing physicians to dif-
ferentiate the expected changes of healthy cognitive aging from
more ominous patterns predictive of neurological disease.
CHALLENGES IN HUMAN STUDIES
Harmonizing the large bodies of work in humans and non-
human species brings forward several challenges. Most obvious
is the fact that human testing is almost always managed through
the interface of language. While it may seem simplest to develop
experimental tests that do not depend on verbal information, the
validity of those tests for humans who developed and operate
in a verbal world will require close examination. For instance,
even among presumably non-verbal neuropsychological tests,
factors such as culture and educational achievement significantly
influence performance (Rosselli and Ardila, 2003).
Human subjects generally represent a much less homogeneous
population than non-human experimental animals. Diseases,
both age-related and not, and the effects of medications used to
treat them, are much more difficult to control in human samples.
Similarly, non-disease, non-cognitive changes with aging, such as
declines in vision and hearing, have major impacts on cognitive
performance. However, these may not be recognized by partic-
ipants or researchers. The NIH Toolbox project has recognized
the importance of these factors and is developing assessments
of sensory, motor, and emotional function that will likely be
useful in studies of human cognitive aging. In their companion
paper in this issue Geldmacher et al. (2012) address the com-
plex issues of identifying and excluding individuals with clinically
relevant disease states from studies of humans, as well as other
hard-to-control variables like gender, culture, and education.
Human studies are also complicated by different approaches to
describing norms. There are few longitudinal studies of domain-
specific cognitive performance in healthy elders. Cross-sectional
data, either treating age as a continuous variable or grouping sub-
jects into cohorts (e.g., age 60–69, 70–79, etc.) is more common.
A particular problemwith cross-sectional methods is the inability
to determine whether a subject is manifesting subclinical findings
of an incipient neurodegenerative disease.
Although a long-term goal of the McKnight Institutes’ ini-
tiative is to assist clinicians to identify and manage cogni-
tive changes in older adults, there are substantial differences
in research and clinical applications of cognitive testing. Most
researchers focus on a single domain of cognition, for instance
breaking down a complex construct like memory into multi-
ple component functions. In contrast, clinicians most often face
complaints that span multiple domains. Even current brief cogni-
tive assessment instruments are used in different ways in clinical
and research paradigms. For instance, the Mini Mental State
Exam may be used to establish an eligibility threshold for more
detailed research assessment, whereas the clinician uses it as the
whole of the cognitive assessment. Clinicians also have a need
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for tests that provide a high degree of discrimination between
what is normal (or acceptable) and what represents disease, while
researchers’ needs may be met by tests that change predictably
over time.
Two other emerging factors may change the role for age-
sensitive cognitive tests in clinical settings over the next decade.
One is the continued evolution of user-friendly, inexpensive,
internet-based cognitive testing. There are currently many of
these programs available for use in clinical research, and others
aimed at self-improvement and cognitive fitness. Taken in con-
junction with ever-increasing rates of computer literacy among
those classified as elderly, additional new paradigms for cognitive
assessment in aging can be anticipated. This is an opportunity
as well as a challenge, since new computer-based cognitive tests
can be modeled after existing assessments for non-human species
and individualized to ameliorate age-related sensory changes
(e.g., visual contrast sensitivity losses). Another important
development is the release and undoubted further refinement
of pathophysiologic biomarkers for age-related illnesses like
Alzheimer’s disease. A diagnostic test that a physician can order
without the need for bedside cognitive assessment and without
accounting for factors like age, gender, education, culture, and
concomitant conditions will likely find a high rate of adoption.
In the companion articles in this special issue we will address
critical aspects of age-related cognition in non-human species,
and how they relate to the assessment of human cognitive
aging. We will also address important considerations for inter-
preting studies of cognition in human subjects. We anticipate
laying the groundwork for the development of a library of
tests that can be applied across species, and suggest domains
where new testing paradigms would advance the field. Finally,
we hope to identify practical outcomes from this work that
will allow clinicians to be more effective in characterizing cog-
nitive changes in older adult patients presenting with memory
concerns.
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